Clinton Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,425
Closed -$295K 375
2018
Q2
$295K Sell
1,425
-992
-41% -$211K 0.05% 304
2018
Q1
$499K Buy
+2,417
New +$507K 0.05% 275
2017
Q4
Sell
-9,432
Closed -$1.78M 499
2017
Q3
$1.78M Sell
9,432
-222
-2% -$40.2K 0.2% 143
2017
Q2
$1.68M Sell
9,654
-52,405
-84% -$8.8M 0.17% 185
2017
Q1
$9.53M Buy
+62,059
New +$9.49M 0.55% 26
2016
Q4
Sell
-108,806
Closed -$17.3M 1006
2016
Q3
$17.3M Buy
+108,806
New +$16.8M 0.81% 6
2015
Q3
Sell
-6,231
Closed -$809K 835
2015
Q2
$809K Buy
6,231
+3,257
+110% +$425K 0.11% 286
2015
Q1
$400K Buy
2,974
+1,206
+68% +$155K 0.1% 291
2014
Q4
$222K Buy
+1,768
New +$215K 0.07% 406
2014
Q3
Sell
-4,018
Closed -$474K 478
2014
Q2
$474K Buy
+4,018
New +$473K 0.24% 159
2013
Q3
Sell
-6,060
Closed -$513K 418
2013
Q2
$513K Buy
+6,060
New +$504K 0.17% 132

Other funds holding TMO

Clinton Group's TMO Position: Q3 2018 in Review

Clinton Group sold out of Thermo Fisher Scientific (TMO) in Q3 2018, closing a stake of 1,425 shares — an estimated $295K sold.

Clinton Group first reported a position in TMO in Q2 2013 and held it in 11 quarters. The position peaked at $17.3M in Q3 2016. 1,350 funds tracked by Wall St. Rank hold TMO as of Q3 2018.

  • Clinton Group reported no remaining Thermo Fisher Scientific position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 1,425 Thermo Fisher Scientific shares in Q3 2018, an estimated $295K.
  • Clinton Group first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 11 quarters.
  • Clinton Group's Thermo Fisher Scientific position peaked at $17.3M in Q3 2016.
  • 1,350 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.